These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4358778)

  • 1. Plasma unconjugated and conjugated 17-hydroxycorticosteroids in different clinical disorders.
    Pal SB
    Clin Endocrinol (Oxf); 1973 Apr; 2(2):141-51. PubMed ID: 4358778
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids in human blood. 3. Free and conjugated 17-hydroxycorticosteroids in healthy people and patients with Cushing's syndrome, before and after administration of corticotrophin.
    Kornel L
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):13-35. PubMed ID: 4308287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 4. [The concentration of unconjugated 17-hydroxycorticosteroids in plasma in Itsenko-Cushing disease].
    Kazanskaia GA; Naryzhniuk ND
    Probl Endokrinol (Mosk); 1971; 17(1):6-9. PubMed ID: 5111953
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous Graves' disease and Cushing's syndrome with unusually low levels of plasma cortisol.
    Kreines K; Esselborn VM
    J Clin Endocrinol Metab; 1968 Jun; 28(6):789-94. PubMed ID: 4297790
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal diurnal variation of plasma cortisol in patients with renovascular hypertension.
    Cade R; Shires DL; Barrow MV; Thomas WC
    J Clin Endocrinol Metab; 1967 Jun; 27(6):800-6. PubMed ID: 4290733
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of serum (and urinary) 17-hydroxycorticosteroids and 17-ketosteroids].
    Iwai K; Honda H
    Nihon Rinsho; 1976; 34 suppl():2112-31. PubMed ID: 186650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diurnal variation of plasma cortisol concentration in patients with various diseases and negative feedback mechanism of the pituitary-adrenal axis].
    Hasui K
    Nihon Naibunpi Gakkai Zasshi; 1969 Sep; 45(6):613-34. PubMed ID: 4310447
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of Cushing's disease with paradoxical response to dexamethasone].
    Kubo M; Nakagawa K; Akikawa K; Matsubara M; Ishizuka T; Nakagawa S
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):75-82. PubMed ID: 3009668
    [No Abstract]   [Full Text] [Related]  

  • 11. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 12. Cushing's disease without hypercortisolism.
    Dexter RN; Orth DN; Abe K; Nicholson WE; Liddle GW
    J Clin Endocrinol Metab; 1970 May; 30(5):573-9. PubMed ID: 4315478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of Cushing's syndrome with the rapid inhibition test].
    Laurencet FL; Jenny M; Muller AF
    Rev Med Suisse Romande; 1968 Nov; 88(11):819-24. PubMed ID: 5747476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of Cushing's syndrome].
    Laurencet FL; Jenny M; Muller AF
    Schweiz Rundsch Med Prax; 1970 Oct; 59(42):1454-67. PubMed ID: 4321069
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent progress in diagnosis of Cushing's disease].
    Teramoto A
    No Shinkei Geka; 1997 Jan; 25(1):7-15. PubMed ID: 8990462
    [No Abstract]   [Full Text] [Related]  

  • 17. [A fluorimetric assay for unconjugated 11-beta-hydroxy-corticosteroids in small serum samples (0.1--0.3ml) and their value in pediatric endocrine diagnosis].
    Geisen K; Mahal S; Schwenk A
    Z Kinderheilkd; 1969; 107(2):175-90. PubMed ID: 4312329
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations and comments on failure of dexamethasone suppression.
    Linn JE; Bowdoin B; Farmer TA; Meador CK
    N Engl J Med; 1967 Aug; 277(8):403-5. PubMed ID: 4378314
    [No Abstract]   [Full Text] [Related]  

  • 19. Selected cases of Cushing's syndrome and the circadian subsystem of plasma hydroxycorticosteroids.
    Giusti G; Borghi A; Romano S; Piolanti P; Serio M
    Int J Chronobiol; 1973; 1(2):173-8. PubMed ID: 4773586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma 17-hydroxycorticosteroids (OHCS) and 17-ketosteroids (KS) (including urinary contents): interpretation of the test results in the field of internal medicine].
    Iwai K; Yawata M; Tamura Y; Sako Y; Honda H
    Nihon Rinsho; 1969 Mar; ():Suppl:906-20. PubMed ID: 4948301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.